Analyst stock forecast
Arcturus Therapeutics Holdings Forecast: $23.80 Analyst Target
Direct answer
Arcturus Therapeutics Holdings's average price target is $23.80.
The target implies +130.2% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies -13%, the high target implies +296.5%, and the range spans 309.5% of the current price.
Forecast evidence checked October 18, 2026.
Get free Arcturus Therapeutics Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $10.34
- Average price target
- $23.80
- High price target
- $41.00
- Low price target
- $9.00
- Low target gap
- -13%
- Target upside
- +130.2%
- High target gap
- +296.5%
- Target range width
- 309.5%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is Arcturus Therapeutics Holdings's average price target?
Arcturus Therapeutics Holdings's verified average price target is $23.80. The target range is $9.00 to $41.00.
How far are Arcturus Therapeutics Holdings's low and high targets from the recorded price?
The low target implies -13%, while the high target implies +296.5%.
How many analysts are included in Arcturus Therapeutics Holdings's consensus?
The verified consensus includes 10 analysts.
How is Arcturus Therapeutics Holdings's target upside or downside calculated?
The average target of $23.80 is divided by the recorded price of $10.34, then one is subtracted to produce +130.2%. This does not guarantee a future return.
When was Arcturus Therapeutics Holdings's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.